KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Ionis Pharmaceuticals (IONS) Asset Utilization Ratio (2016 - 2026)

Ionis Pharmaceuticals (IONS) has disclosed Asset Utilization Ratio for 17 consecutive years, with 0.25 as the latest value for Q1 2026.

  • For Q1 2026, Asset Utilization Ratio rose 2.81% year-over-year to 0.25; the TTM value through Mar 2026 reached 0.25, up 2.81%, while the annual FY2025 figure was 0.29, 22.89% up from the prior year.
  • Asset Utilization Ratio hit 0.25 in Q1 2026 for Ionis Pharmaceuticals, up from 0.23 in the prior quarter.
  • Across five years, Asset Utilization Ratio topped out at 0.3 in Q2 2024 and bottomed at 0.18 in Q1 2022.
  • Average Asset Utilization Ratio over 5 years is 0.24, with a median of 0.24 recorded in 2022.
  • On a YoY basis, Asset Utilization Ratio climbed as much as 38.49% in 2024 and fell as far as 12.84% in 2024.
  • Ionis Pharmaceuticals' Asset Utilization Ratio stood at 0.24 in 2022, then grew by 12.18% to 0.27 in 2023, then dropped by 12.84% to 0.23 in 2024, then increased by 1.29% to 0.23 in 2025, then increased by 8.01% to 0.25 in 2026.
  • According to Business Quant data, Asset Utilization Ratio over the past three periods came in at 0.25, 0.23, and 0.26 for Q1 2026, Q4 2025, and Q3 2025 respectively.